Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,765 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Recruiting

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

NCT06864026

Conditions
Arthritis, Arthritis, Psoriatic, Body Weight, +20 more
Locations
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Avondale Avondale, Arizona, United States
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler Chandler, Arizona, United States
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Flagstaff Flagstaff, Arizona, United States
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Gilbert Gilbert, Arizona, United States
View all 55 locations
View Trial Details
Recruiting

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

NCT06857942

Conditions
Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +10 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • First OC Dermatology Research Inc Fountain Valley, California, United States
  • Center For Dermatology Clinical Research, Inc. Fremont, California, United States
  • Metropolis Dermatology Los Angeles, California, United States
View all 39 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

NCT06979453

Conditions
Exanthema, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +7 more
Locations
  • Local Institution - 0261 Birmingham, Alabama, United States
  • Local Institution - 0041 Birmingham, Alabama, United States
  • Local Institution - 0053 Phoenix, Arizona, United States
  • Local Institution - 0025 Fountain Valley, California, United States
View all 132 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

NCT07775924

Conditions
Cutaneous Lichen Planus, Lichen Planus, Lichenoid Eruptions, +3 more
Locations
  • Cahaba Derm and skin hlth ctr 27 Birmingham, Alabama, United States
  • Dawes Fretzin Clinical Rea Group Indianapolis, Indiana, United States
  • Delricht Research New Orleans, Louisiana, United States
  • Novartis Investigative Site Waitara, New South Wales, Australia
View Trial Details
Recruiting

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

NCT06100744

Conditions
Arthritis, Arthritis, Juvenile, Arthritis, Psoriatic, +16 more
Locations
  • Arkansas Children's Hospital /ID# 258776 Little Rock, Arkansas, United States
  • Childrens National Medical Center /ID# 259284 Washington D.C., District of Columbia, United States
  • Joe Dimaggio Children's Hospital Hollywood /ID# 260634 Hollywood, Florida, United States
  • All X Ray Diagnostic Services Corp /ID# 278523 Miami, Florida, United States
View all 34 locations
View Trial Details
Recruiting

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

NCT07013201

Conditions
Palmoplantar Pustulosis, Psoriasis, Skin Diseases, +2 more
Locations
  • LEO Pharma Investigational Site Fountain Valley, California, United States
  • LEO Pharma Investigational Site Douglasville, Georgia, United States
  • LEO Pharma Investigational Site West Bloomfield, Michigan, United States
  • LEO Pharma Investigational Site Elmhurst, New York, United States
View all 39 locations
View Trial Details

Related conditions